WallStreetZenWallStreetZen

NYSE: BDX
Becton Dickinson & Co Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Becton Dickinson & Co earnings were $1.1B for the trailing 12 months ending Mar 31, 2026, with -23.7% growth year over year. The latest BDX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$311.0M, down 181.4% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, BDX reported annual earnings of $1.7B, with -1.6% growth.

BDX past earnings growth

How has BDX's earnings growth performed historically?

Company
-23.75%
Industry
7.9%
Market
84.84%
BDX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BDX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BDX's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BDX earnings history

Current Revenue
$21.4B
Current Earnings
$1.1B
Current Profit Margin
5.3%
BDX's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BDX Return on Equity

Current Company
4.5%
Current Industry
9.9%
Current Market
5.2%
BDX's Return on Equity (4.5%)... subscribe to Premium to read more.
High Return on Equity Performance

BDX Return on Assets

Current Company
2.1%
Current Industry
8.3%
BDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BDX announces earnings.

BDX Return on Capital Employed

Current Company
4.68%
Current Industry
11.9%
BDX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BDX vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BDX$4.36B$1.14B-6.91%$3.95
ALC$2.55B$819.00M+15.45%$1.67
MDLNN/AN/AN/AN/A
RMD$2.14B$1.52B+26.90%$10.40
WST$863.50M$542.70M+5.62%$7.52
View Top Medical Stocks

Becton Dickinson & Co Earnings Reports & History FAQ

What were Becton Dickinson & Co's earnings last quarter?

On BDX's earnings call on Invalid Date, Becton Dickinson & Co (NYSE: BDX) reported Q1 2026 earnings per share (EPS) of -$1.11, up 203.74% year over year. Total BDX earnings for the quarter were -$311.00 million. In the same quarter last year, Becton Dickinson & Co's earnings per share (EPS) was $1.07.

If you're new to stock investing, here's how to buy Becton Dickinson & Co stock.

Is Becton Dickinson & Co profitable or losing money?

As of the last Becton Dickinson & Co earnings report, Becton Dickinson & Co is currently profitable. Becton Dickinson & Co's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $1.14 billion, a 24.03% decrease year over year.

What was BDX's earnings growth in the past year?

As of Becton Dickinson & Co's earnings date in Invalid Date, Becton Dickinson & Co's earnings has grown -23.75% year over year. This is 31.64 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 7.9%. BDX earnings in the past year totalled $1.14 billion.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.